Calabrese leonard (3 Ergebnisse)

Autor
Mit der Detailsuche verfeinern

Optimieren Sie Ihre Suche

  • Bücher (3)

  • Neu (3)

bis

Benutzerdefinierte Preisspanne (EUR)

bis

    • Sprache: Englisch

      Verlag: Elsevier Health Sciences, 2017

      032349675X / 9780323496759

      • Hardcover

      Anbieter: moluna, Greven, Deutschlandmoluna

      Verkäufer/-in mit 5 Sternen
      Verkäufer/-in kontaktieren

      Zustand: Neu

      EUR 102,25

      EUR 48,99 Versand 
      Versand von Deutschland nach USA

      Anzahl: 1 verfügbar

      Zustand: New. This issue of Rheumatic Disease Clinics will include articles such as: Vaccines and Biologics- efficacy and toxicity Improving Vaccine administration in Practice HCV and rheumatology HBV reactivation and rheumatic disease Herpes zoster in rheumatic dise.

    • Sprache: Englisch

      Verlag: Springer Nature, 2021

      3030568237 / 9783030568238

      • Softcover

      Anbieter: Revaluation Books, Exeter, Vereinigtes KönigreichRevaluation Books

      Verkäufer/-in mit 5 Sternen
      Verkäufer/-in kontaktieren

      Zustand: Neu

      EUR 168,13

      EUR 14,60 Versand 
      Versand von Vereinigtes Königreich nach USA

      Anzahl: 1 verfügbar

      Paperback. Zustand: Brand New. 363 pages. 7.99x5.00x0.80 inches. In Stock.

    • Sprache: Englisch

      Verlag: Springer, 2021

      3030568237 / 9783030568238

      • Softcover

      Anbieter: AHA-BUCH GmbH, Einbeck, DeutschlandAHA-BUCH GmbH

      Verkäufer/-in mit 5 Sternen
      Verkäufer/-in kontaktieren

      Zustand: Neu

      EUR 166,33

      EUR 30,50 Versand 
      Versand von Deutschland nach USA

      Anzahl: 1 verfügbar

      Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - With the increasing use of immune checkpoint inhibitors (ICI) across various cancers, the trends for indication at earlier stages, and the use of combination immunotherapy, the frequency of ICI-induced immune-related adverse events (irAE) is expected to grow substantially. Management of these irAE is challenging as it requires not only consideration of the toxicity but also risk-benefit ratios with respect to the primary cancer. Several rheumatic irAE have been reported with ICI therapy including arthritis, myositis, polymyalgia-like syndromes, sicca/Sjogren-like manifestations, and several other less common systemic autoimmune features commonly associated with connective tissue disease. This handbook provides clinicians with a comprehensive overview of the management of rheumatic irAE that develop from cancer immunotherapy. It focuses on the irAE seen with ICI, the most frequently used agents in treating cancer. It provides an overview of cancer immunology,immunotoxicity, and immunotherapies such as ICI, cytokine-based therapy, and CART. It examines the epidemiology, clinical manifestations, diagnosis, differential diagnosis, and treatment of a variety of rheumatic immune-related adverse events arising from these therapies. Chapters also cover cancer immunotherapy in patients with preexisting rheumatic diseases such as inflammatory arthritis and other connective tissue disorders. The book helps clinicians to distinguish the current types of cancer immunotherapy and general toxicity patterns, recognize and diagnose rheumatic clinical syndromes, understand the pathogenesis of irAE, and consider risk-benefit ratios when managing patients with rheumatic irAE.Rheumatic Diseases and Syndromes Induced by Cancer Immunotherapy is an essential resource for physicians and related professionals, residents, fellows, graduate students and nurses alike in rheumatology, clinical immunology, oncology, and internal medicine.